We evaluated CaM levels in HD and HNSCC T cells by measuring the fluorescence intensity of CaM at the cell membrane (defined by the CD8 staining) as well as in the cytoplasm. The gene discussed is CALM2; the disease is head and neck squamous cell carcinoma.